A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

Endostatin may predict mortality and kidney impairment in general populations as well as in critically ill patients. We decided to explore the possible role of endostatin as a predictor of 30-day mortality, acute kidney injury (AKI), and renal replacement therapy (RRT) in a cohort of unselected inte...

Full description

Bibliographic Details
Main Authors: Toralph Ruge, Anders Larsson, Miklós Lipcsey, Jonas Tydén, Joakim Johansson, Mats Eriksson
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Biomedicines
Subjects:
acute kidney injury
critical illness
endostatin
epidemiology
intensive care unit
mortality
Online Access:https://www.mdpi.com/2227-9059/9/11/1603

Similar Items

Similar Items